Promedior's PRM-151 clinical data in idiopathic pulmonary fibrosis to be presented at ATS 2011

Download PDF Copy

May 5 2011

NewsGuard 100/100 Score

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, today announced that data from a clinical study of PRM-151 (recombinant human Pentraxin-2 (PTX-2)) will be presented at the 2011 American Thoracic Society International Conference (ATS 2011), being held May 13-18, 2011 in Denver, CO.

The poster presentation includes clinical data from a completed Phase 1 study of PRM-151 that evaluated comprehensive safety endpoints and exploratory biomarker activity in healthy subjects and IPF patients. The data to be presented highlight the safety, tolerability, and biomarker activity of Pentraxin-2 therapeutics in patients with idiopathic pulmonary fibrosis (IPF).

Source: Promedior, Inc.

Posted in: Drug Trial News | Medical Condition News

Tags: Anti-Inflammatory, Biomarker, Biotechnology, Cell, Diabetic Retinopathy, Fibrosis, Glaucoma, Idiopathic Pulmonary Fibrosis, Pathology, Protein, Pulmonary Fibrosis, Scleroderma, Therapeutics

Comments (0)

Download PDF Copy

Suggested Reading

Curcumin shows promise in preventing and treating oral submucosal fibrosis

Curcumin shows promise in preventing and treating oral submucosal fibrosis

Arthritis-style immunotherapy shows promise for heart failure

Arthritis-style immunotherapy shows promise for heart failure

One-time prime editing targets common genetic cause of cystic fibrosis

One-time prime editing targets common genetic cause of cystic fibrosis

Hypothalamic ECM remodeling drives insulin resistance, contributing to obesity and diabetes

Hypothalamic ECM remodeling drives insulin resistance, contributing to obesity and diabetes

Regulatory T cells exist as large, mobile population that travels through body to repair damaged tissue

Regulatory T cells exist as large, mobile population that travels through body to repair damaged tissue

Liver receptor mutations linked to liver dysfunction, cholesterol accumulation, and hepatitis

Liver receptor mutations linked to liver dysfunction, cholesterol accumulation, and hepatitis

The consumption of flavonoid-rich foods was associated with a reduced risk of NAFLD among middle-aged adults

The consumption of flavonoid-rich foods was associated with a reduced risk of NAFLD among middle-aged adults

Breakdancer’s scalp mass removed after years of headspin injuries

Breakdancer’s scalp mass removed after years of headspin injuries

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Heart failure triggers multimorbidity by altering stem cells, study reveals